James Kim

Title: Innovations of James Kim in Transdermal Therapeutics

Introduction

James Kim is an accomplished inventor based in Stanford, CA (US). He has made significant contributions to the field of transdermal drug delivery, particularly in the treatment of skin cancers. His innovative approach focuses on the use of topical formulations to enhance therapeutic outcomes.

Latest Patents

James Kim holds a patent for "Topical itraconazole formulations and uses thereof." This patent describes methods for transdermally delivering a therapeutic amount of a triazole-triazolone compound, specifically for the prevention or treatment of basal cell carcinoma (BCC) in a subject. The patent emphasizes the delivery of a therapeutic level of itraconazole through the skin, providing a novel approach to cancer treatment.

Career Highlights

Throughout his career, James Kim has worked with prestigious institutions such as Leland Stanford Junior University and Children's Hospital & Research Center Oakland. His work has focused on developing innovative therapeutic solutions that address significant medical challenges.

Collaborations

James has collaborated with notable colleagues, including Jean Tang and Philip Arden Beachy. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

James Kim's contributions to transdermal therapeutics exemplify the impact of innovative thinking in medicine. His work continues to pave the way for new treatment options for patients with skin cancer.